Fig. 2
SOX9, but not CK19, is associated with survival time of iCCA patients. Kaplan–Meier survival analysis shows the association between SOX9 (a, c)/CK19 expression (b, d) and survival time in 59 iCCA patients.
Fig. 2 | British Journal of Cancer
SOX9, but not CK19, is associated with survival time of iCCA patients. Kaplan–Meier survival analysis shows the association between SOX9 (a, c)/CK19 expression (b, d) and survival time in 59 iCCA patients.
